Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 3,616,099 | reported | 22 May 2014 | tx 14+4,289,582−23,738,677 |
| KalVista Pharmaceuticals, Inc. | 3,133,060 | reported | 14 Apr 2015 | tx 9+4,343,550−3,466,050 |
| Neothetics, Inc. | 2,595,257 | reported | 25 Nov 2014 | tx 19+2,906,052−15,159,645 |
| Esperion Therapeutics, Inc. | 2,552,189 | reported | 21 Oct 2014 | tx 1+500,000 |
| TALPHERA, INC. | 2,507,974 | reported | 20 Sept 2013 | tx 23+2,837,120−2,050,728 |
| OCCAM NETWORKS INC/DE | 1,879,088 | reported | 07 Nov 2006 | tx 3+1,879,088−2,125,088 |
| CUTERA INC | 30,000 | reported | 10 May 2004 | tx 4+1,405,000−1,750,000 |
| Bioventus Inc. | 25,146 | reported | 03 Jun 2026 | tx 22+301,561−2,731,787 |
| TELA Bio, Inc. | 23,600 | reported | 09 Jun 2026 | tx 4+58,485 |
| Allakos Inc. | 19,457 | reported | 04 Mar 2021 | tx 9−33,460 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jun 2026 | GRANT_AWARD | TELA Bio, Inc. | 11,925 | 0.00 USD | |
| 09 Jun 2026 | GRANT_AWARD | TELA Bio, Inc. | 11,675 | 0.00 USD | |
| 09 Jun 2026 | GRANT_AWARD | TELA Bio, Inc. | 17,550 | 0.00 USD | deriv |
| 09 Jun 2026 | GRANT_AWARD | TELA Bio, Inc. | 17,335 | 0.00 USD | deriv |
| 02 Jun 2026 | EXERCISE | Bioventus Inc. | 32,282 | 0.00 USD | |
| 02 Jun 2026 | EXERCISE | Bioventus Inc. | 32,282 | 0.00 USD | deriv |
| 03 Jun 2026 | GRANT_AWARD | Bioventus Inc. | 25,146 | 0.00 USD | deriv |
| 04 Dec 2025 | SALE | Bioventus Inc. | 10,000 | 7.57 USD | |
| 02 Jun 2025 | EXERCISE | Bioventus Inc. | 26,493 | 0.00 USD | |
| 02 Jun 2025 | EXERCISE | Bioventus Inc. | 26,493 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Bioventus Inc. | 32,282 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Bioventus Inc. | 26,493 | 0.00 USD | deriv |
| 07 Jun 2024 | EXERCISE | Bioventus Inc. | 30,400 | 0.00 USD | |
| 07 Jun 2024 | EXERCISE | Bioventus Inc. | 30,400 | 0.00 USD | deriv |
| 16 Aug 2023 | OTHER | Bioventus Inc. | 41,369 | 0.00 USD | |
| 06 Jun 2023 | EXERCISE | Bioventus Inc. | 16,648 | 0.00 USD | |
| 06 Jun 2023 | EXERCISE | Bioventus Inc. | 16,648 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Bioventus Inc. | 30,400 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Bioventus Inc. | 16,648 | 0.00 USD | deriv |
| 01 Apr 2022 | EXERCISE | Bioventus Inc. | 2,700 | — | |
| 01 Apr 2022 | EXERCISE | Bioventus Inc. | 2,700 | 0.00 USD | deriv |
| 11 Feb 2022 | EXERCISE | Bioventus Inc. | 9,000 | — | |
| 11 Feb 2022 | EXERCISE | Bioventus Inc. | 9,000 | 0.00 USD | deriv |
| 01 Apr 2021 | GRANT_AWARD | Bioventus Inc. | 2,700 | 0.00 USD | deriv |
| 04 Mar 2021 | SALE | Allakos Inc. | 5,886 | 111.80 USD |
1 purchase reported after at least 12 months of silence — most recent on 30 Oct 2013.